Catalio Capital Management LP Acquires Shares of 25,505 Billiontoone, Inc. $BLLN

by · The Cerbat Gem

Catalio Capital Management LP acquired a new stake in shares of Billiontoone, Inc. (NASDAQ:BLLN – Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 25,505 shares of the company’s stock, valued at approximately $2,087,000. Catalio Capital Management LP owned 0.06% of Billiontoone at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of BLLN. Green Alpha Advisors LLC acquired a new stake in Billiontoone during the 4th quarter valued at approximately $436,000. FNY Investment Advisers LLC acquired a new stake in Billiontoone during the 4th quarter valued at approximately $497,000. Massachusetts Financial Services Co. MA acquired a new stake in Billiontoone during the 4th quarter valued at approximately $13,373,000. Baillie Gifford & Co. acquired a new stake in Billiontoone during the 4th quarter valued at approximately $103,786,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Billiontoone during the 4th quarter valued at approximately $1,348,000.

Billiontoone Stock Performance

BLLN opened at $99.38 on Thursday. The company has a debt-to-equity ratio of 0.18, a current ratio of 10.92 and a quick ratio of 10.58. The firm has a fifty day moving average price of $89.23 and a 200 day moving average price of $87.40. Billiontoone, Inc. has a 1 year low of $61.96 and a 1 year high of $138.70. The stock has a market cap of $4.57 billion and a P/E ratio of 180.69.

Billiontoone (NASDAQ:BLLN – Get Free Report) last posted its earnings results on Wednesday, May 6th. The company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.33. The firm had revenue of $108.39 million during the quarter, compared to analyst estimates of $95.81 million. During the same quarter in the prior year, the firm earned ($0.39) earnings per share. The business’s revenue for the quarter was up 83.8% on a year-over-year basis. Equities research analysts anticipate that Billiontoone, Inc. will post 0.93 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts have commented on the stock. Weiss Ratings cut shares of Billiontoone from a “sell (d+)” rating to a “sell (d)” rating in a research note on Friday, June 5th. Guggenheim lifted their price objective on shares of Billiontoone from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, May 13th. JPMorgan Chase & Co. lifted their price objective on shares of Billiontoone from $120.00 to $125.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th. BTIG Research decreased their target price on shares of Billiontoone from $140.00 to $130.00 and set a “buy” rating for the company in a research note on Thursday, May 7th. Finally, Wells Fargo & Company decreased their target price on shares of Billiontoone from $110.00 to $90.00 and set an “equal weight” rating for the company in a research note on Thursday, March 5th. Six research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Billiontoone has a consensus rating of “Moderate Buy” and a consensus target price of $125.29.

Check Out Our Latest Analysis on BLLN

Insider Transactions at Billiontoone

In other Billiontoone news, CTO David Tsao sold 20,000 shares of the company’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $102.27, for a total transaction of $2,045,400.00. Following the completion of the transaction, the chief technology officer directly owned 1,000 shares in the company, valued at approximately $102,270. This represents a 95.24% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Shan Riku Sakakibara sold 8,000 shares of the company’s stock in a transaction on Monday, June 8th. The stock was sold at an average price of $98.22, for a total transaction of $785,760.00. Following the transaction, the insider owned 212,000 shares of the company’s stock, valued at $20,822,640. This represents a 3.64% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 83,582 shares of company stock worth $8,312,361.

Billiontoone Profile

(Free Report)

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.

Read More

Want to see what other hedge funds are holding BLLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Billiontoone, Inc. (NASDAQ:BLLN – Free Report).